Alan Colman - 22 Jan 2026 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Reporting relationship: Director
Issuer ticker: VNRX
Reported as of: 22 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Jan 2026, 16:07:35 UTC
Prior SEC filing: 04 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Alan Colman

Key filing fact

Alan Colman filed Form 4 for VOLITIONRX LTD (VNRX) on 23 Jan 2026.

Key facts

This page summarizes Alan Colman's Form 4 filing for VOLITIONRX LTD (VNRX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Jan 2026, 16:07.

Change

Previous filing in this sequence was filed on 04 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001577873 Primary reporting owner

Colman Alan

Relationship: Director
Address: 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON
Signature: /s/ Alan Colman
Signature date: 23 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VNRX transaction

Common Stock

Award

Transaction value: $0
Shares: +12,000
Change %: +4.9%
Price: $0.000000
Shares after: 257,364
Date: 22 Jan 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On March 17, 2025, the reporting person was awarded 40,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.